miR-1908-5p is downregulated in CRC, correlates with TNM stage, nodal metastasis, elevated CA19-9 levels, and poor survival, and suppresses CRC cell proliferation, migration, and invasion by directly targeting SCAMP4, thereby qualifying as a potential prognostic biomarker for CRC.
Yuan et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: